Trial Outcomes & Findings for Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) (NCT NCT00590980)

NCT ID: NCT00590980

Last Updated: 2017-11-17

Results Overview

Definite fatal and nonfatal ischemic stroke in the vertebrobasilar territory

Recruitment status

COMPLETED

Target enrollment

82 participants

Primary outcome timeframe

up to 27 months

Results posted on

2017-11-17

Participant Flow

Participant milestones

Participant milestones
Measure
All Study Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
Overall Study
STARTED
82
Overall Study
COMPLETED
72
Overall Study
NOT COMPLETED
10

Reasons for withdrawal

Reasons for withdrawal
Measure
All Study Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
Overall Study
Did not meet all inclusion criteria
10

Baseline Characteristics

Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Study Participants
n=72 Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
Age, Continuous
65.6 years
n=5 Participants
Sex: Female, Male
Female
32 Participants
n=5 Participants
Sex: Female, Male
Male
40 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
64 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
4 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
18 Participants
n=5 Participants
Race (NIH/OMB)
White
49 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
Region of Enrollment
Canada
6 participants
n=5 Participants
Region of Enrollment
United States
66 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 27 months

Population: Study participants meeting all inclusion and exclusion criteria

Definite fatal and nonfatal ischemic stroke in the vertebrobasilar territory

Outcome measures

Outcome measures
Measure
Study Participants
n=72 Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
Fatal and Nonfatal Ischemic Stroke in the Vertebrobasilar Territory
72 Participants

Adverse Events

Observation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sepideh Amin-Hanjani, MD

University of Illinois at Chicago

Phone: 312-996-4842

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place